Chronic kidney disease(CKD)comprises a group of clinical syndromes affecting kidney structure and function,with various causes,high treatment costs,and a poor prognosis.Epigenetic modification of gene expression and cell function has been shown to play a key regulatory role in the occurrence and development of CKD.Homocysteine(Hey)is a common amino acid-containing thiol group in the body.Hyperhomocysteinemia(HHcy)is a damaging condition involving many organs,and is an independent predictor of end-stage renal disease morbidity and mortality.This review considers the relationship between HHcy and chronic renal injury,and examines research progress in the role of epigenetic modification in the mechanism of Hcy-mediated chronic renal injury,with the aim of furthering our understanding of the occurrence and development of CKD.This process and its mechanism provide new ideas and a theoretical basis for further research into CKD.

Objective:To investigate the drug resistance gene characteristics, plasmid characteristics and genome tracing of Shigella sonnei causing a bacillary dysentery outbreak in Shandong Province. Methods:Sixty-five Shigella sonnei strains isolated from a 2021 outbreak in a county of Shandong Province were analyzed using antimicrobial susceptibility testing, whole genome sequencing (WGS), characterization of resistance and virulence genes, plasmid profiling, core genome multilocus sequence typing (cgMLST), and single nucleotide polymorphism (SNP) analysis. Results:All isolates had the same resistance phenotype and genotypes and were multidrug-resistant ESBL-producing Shigella sonnei, carrying important virulence genes. Plasmid analysis revealed a conserved genetic arrangement, pil( M/ N/ O2/ P)-tra( F/ H/ J/ K/ N/ O/ P/ Q)-IS Ecp1- blaCTX-M-14-Tn 903- yub( J/ I/ F/ G/ E/ D), and shared across strains from diverse regions and bacterial species. The cgMLST and SNP analyses demonstrated concordant clustering, with all 65 outbreak-related strains forming a single cluster alongside human-derived strains from Guangxi. Conclusion:The ESBL-producing Shigella sonnei responsible for the outbreak shares a homologous relationship with Guangxi human-derived strains, and the detected resistance plasmids and virulence genes underscore the need to strengthen drug resistance surveillance and genome tracing.

BACKGROUND: Generalized pustular psoriasis (GPP), a rare and recurrent autoinflammatory disease, imposes a substantial burden on patients and society. Awareness of GPP in China remains limited. METHODS: This cross-sectional survey, conducted between September 2021 and May 2023 across 14 hospitals in China, included GPP patients of all ages and disease phases. Data collected encompassed demographics, clinical characteristics, economic impact, disease severity, quality of life, and treatment-related complications. Risk factors for GPP recurrence were analyzed. RESULTS: Among 127 patients (female/male ratio = 1.35:1), the mean age of disease onset was 25 years (1st quartile [Q1]-3rd quartile [Q3]: 11-44 years); 29.2% had experienced GPP for more than 10 years. Recurrence occurred in 75.6% of patients, and nearly half reported no identifiable triggers. Younger age at disease onset ( P  = 0.021) and transitioning to plaque psoriasis ( P  = 0.022) were associated with higher recurrence rates. The median diagnostic delay was 8 months (Q1-Q3: 2-41 months), and 32.3% of patients reported misdiagnoses. Comorbidities were present in 53.5% of patients, whereas 51.1% experienced systemic complications during treatment. Depression and anxiety affected 84.5% and 95.6% of patients, respectively. During GPP flares, the median Dermatology Life Quality Index score was 19.0 (Q1-Q3: 13.0-23.5). This score showed significant differences between patients with and without systemic symptoms; it demonstrated correlations with both depression and anxiety scores. Treatment costs caused financial hardship in 55.9% of patients, underscoring the burden associated with GPP. CONCLUSIONS The substantial disease and economic burdens among Chinese GPP patients warrant increased attention. Patients with early onset disease and those transitioning to plaque psoriasis require targeted interventions to mitigate the high recurrence risk.
Humans ; Male ; Female ; Psoriasis/pathology* ; Adult ; Cross-Sectional Studies ; Adolescent ; Child ; Young Adult ; Quality of Life ; Middle Aged ; China/epidemiology* ; Recurrence ; Risk Factors ; Surveys and Questionnaires ; East Asian People

BACKGROUND:The"inflammatory storm"induced by microglia is an important pathological factor causing the death of neuronal cells after spinal cord injury,which is extremely unfavorable for the recovery after spinal cord injury.Dihydroquercetin belongs to the vitamin P group and has excellent biological activity.It has good anti-inflammatory,anti-lipid peroxidation and neuroprotective effects on spinal cord injury.The mechanism by which it promotes the repair of spinal cord injury needs to be further clarified.OBJECTIVE:To investigate whether dihydroquercetin can ameliorate the inflammatory state induced after spinal cord injury through its anti-inflammatory and antioxidant properties for the purpose of protection against spinal cord injury.METHODS:Forty-eight Sprague-Dawley rats were divided into sham operation group,spinal cord injury group,low-dose dihydroquercetin group,and high-dose dihydroquercetin group according to the random number table method.The sham operation group only underwent laminectomy and was given intraperitoneal injection of normal saline after the operation.Animal models of spinal cord injury were made in the latter three groups.After the operation,normal saline,30 mg/kg,and 50 mg/kg dihydroquercetin were given by intraperitoneal injection respectively,and samples were collected 4 weeks after the operation.The Basso-Beatte-Bresnahan(BBB)limb motor function score and mechanical paw withdrawal threshold were used to evaluate the limb motor function and pain recovery of rats.Hematoxylin-eosin staining was used to observe the pathological changes of spinal cord tissue;Nissl staining was used to observe the number of Nissl bodies and the morphology of neurons.The activity of superoxide dismutase in spinal cord tissue was detected.Immunofluorescence was used to detect the expression of reactive oxygen species and microglia Iba1.Western blot was used to detect the protein expression of Iba1 and interleukin-1β,interleukin-6,interleukin-10,tumor necrosis factor-α,and p38 mitogen-activated protein kinase in the spinal cord.RESULTS AND CONCLUSION:(1)In the behavioral test,the BBB limb motor function score showed that since 14 days after the operation,the BBB limb motor function score of the high-dose dihydroquercetin group was significantly better than that of the spinal cord injury group(P<0.01);the mechanical paw withdrawal threshold was significantly lower in the high-dose dihydroquercetin than the spinal cord injury group at 21 days after the operation(P<0.05),and the former group showed better motor function.(2)Hematoxylin-eosin staining and Nissl staining showed that compared with the spinal cord injury group,the high-dose dihydroquercetin group showed slightly swollen but structurally intact and clearer neuron morphology in the spinal cord tissue,and the number of Nissl bodies increased.(3)Superoxide dismutase detection:Compared with the spinal cord injury group,the activity of superoxide dismutase in the spinal cord tissue of the high-dose dihydroquercetin increased significantly(P<0.05).(4)Reactive oxygen species immunofluorescence detection:Compared with the spinal cord injury group,the high-dose dihydroquercetin could significantly reduce the accumulation of reactive oxygen species after spinal cord injury(P<0.05).(5)Detection of microglial marker Iba1:Compared with the spinal cord injury group,the high-dose dihydroquercetin could significantly reduce the expression of microglial marker Iba1 after spinal cord injury(P<0.01).(6)Western blot detection results showed that compared with the spinal cord injury group,the expressions of inflammatory factors(interleukin-1β,interleukin-6,and tumor necrosis factor-α)and phosphorylated p38 mitogen-activated protein kinase in the high-dose dihydroquercetin group decreased significantly(P<0.01),while the expression of anti-inflammatory factor interleukin-10 increased significantly(P<0.01).These findings indicate that dihydroquercetin can effectively reverse the expression changes of multiple inflammatory markers induced after spinal cord injury in rats,thereby exerting neuroprotective effects and improving motor function.

Objective:To evaluate the efficacy and safety of therapeutic temperature control in patients with severe traumatic brain injury (sTBI).Methods:The full-text databases of Chinese Medical Journal, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, VIP Database, China Biomedical Database, PubMed, Embase, and Cochrane Library were searched for randomized controlled trials (RCTs) of hypothermia treatment and conventional treatment in patients with sTBI. The search period was from January 2016 to June 2025. Meta-analysis was performed using RevMan 5.3 software. The evaluation indicators included intracranial pressure before treatment, at 3 and 5 days after treatment, favorable prognosis rate and mortality rate within 6 months after treatment, and incidence of pulmonary infection, intracranial infection, epilepsy, acute gastrointestinal dysfunction, deep vein thrombosis, abnormal coagulation function, and arrhythmia during treatment; publication bias.Results:A total of 33 studies involving 3 322 patients were included, with 1 696 patients in the temperature treatment group and 1 626 in the conventional treatment group. There was no statistically significant difference in intracranial pressure between the two groups before treatment ( SMD=0, 95% CI -0.13, 0.14, P>0.05). However, at 3 and 5 days after treatment, the intracranial pressure was lower in the temperature treatment group than that in the conventional treatment group ( SMD=-2.29, 95% CI -2.76, -1.82, P<0.01; SMD=-2.66, 95% CI -3.43, -1.89, P<0.01). Within 6 months after treatment, the favorable prognosis rate was higher in the temperature treatment group than that in the conventional treatment group ( RR=1.41, 95% CI 1.32, 1.50, P<0.01), and mortality rate was lower than that in the conventional treatment group ( RR=0.64, 95% CI 0.55, 0.75, P<0.01). Compared with the conventional treatment group, the incidences of epilepsy and acute gastrointestinal dysfunction in the temperature treatment group were statistically reduced ( RR=0.33, 95% CI 0.13, 0.83, P<0.05; RR=0.43, 95% CI 0.25, 0.74, P<0.05). There were no statistically significant differences in the incidence of pulmonary infection ( RR=0.96, 95% CI 0.85, 1.08, P>0.05), intracranial infection ( RR=0.56, 95% CI 0.20, 1.56, P>0.05), deep vein thrombosis ( RR=0.93, 95% CI 0.69, 1.25, P>0.05), abnormal coagulation function ( RR=1.19, 95% CI 0.43, 3.31, P>0.05) or arrhythmia ( RR=0.51, 95% CI 0.23, 1.12, P>0.05) between the two groups. Egger′s test indicated the presence of publication bias and the results remained robust after trim and fill analysis. Conclusions:For patients with sTBI, temperature control therapy shows lowered intracranial pressure and mortality rate as well as improved favorable prognosis rate at 6 months posttreatment, and decreased incidence of epilepsy and acute gastrointestinal dysfunction during treatment, while reveals similar incidence of pulmonary infection, intracranial infection, deep vein thrombosis, abnormal coagulation function, and arrhythmia when compared with conventional treatment.

Objective:To investigate the drug resistance gene characteristics, plasmid characteristics and genome tracing of Shigella sonnei causing a bacillary dysentery outbreak in Shandong Province. Methods:Sixty-five Shigella sonnei strains isolated from a 2021 outbreak in a county of Shandong Province were analyzed using antimicrobial susceptibility testing, whole genome sequencing (WGS), characterization of resistance and virulence genes, plasmid profiling, core genome multilocus sequence typing (cgMLST), and single nucleotide polymorphism (SNP) analysis. Results:All isolates had the same resistance phenotype and genotypes and were multidrug-resistant ESBL-producing Shigella sonnei, carrying important virulence genes. Plasmid analysis revealed a conserved genetic arrangement, pil( M/ N/ O2/ P)-tra( F/ H/ J/ K/ N/ O/ P/ Q)-IS Ecp1- blaCTX-M-14-Tn 903- yub( J/ I/ F/ G/ E/ D), and shared across strains from diverse regions and bacterial species. The cgMLST and SNP analyses demonstrated concordant clustering, with all 65 outbreak-related strains forming a single cluster alongside human-derived strains from Guangxi. Conclusion:The ESBL-producing Shigella sonnei responsible for the outbreak shares a homologous relationship with Guangxi human-derived strains, and the detected resistance plasmids and virulence genes underscore the need to strengthen drug resistance surveillance and genome tracing.

Objective:To evaluate the efficacy and safety of therapeutic temperature control in patients with severe traumatic brain injury (sTBI).Methods:The full-text databases of Chinese Medical Journal, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, VIP Database, China Biomedical Database, PubMed, Embase, and Cochrane Library were searched for randomized controlled trials (RCTs) of hypothermia treatment and conventional treatment in patients with sTBI. The search period was from January 2016 to June 2025. Meta-analysis was performed using RevMan 5.3 software. The evaluation indicators included intracranial pressure before treatment, at 3 and 5 days after treatment, favorable prognosis rate and mortality rate within 6 months after treatment, and incidence of pulmonary infection, intracranial infection, epilepsy, acute gastrointestinal dysfunction, deep vein thrombosis, abnormal coagulation function, and arrhythmia during treatment; publication bias.Results:A total of 33 studies involving 3 322 patients were included, with 1 696 patients in the temperature treatment group and 1 626 in the conventional treatment group. There was no statistically significant difference in intracranial pressure between the two groups before treatment ( SMD=0, 95% CI -0.13, 0.14, P>0.05). However, at 3 and 5 days after treatment, the intracranial pressure was lower in the temperature treatment group than that in the conventional treatment group ( SMD=-2.29, 95% CI -2.76, -1.82, P<0.01; SMD=-2.66, 95% CI -3.43, -1.89, P<0.01). Within 6 months after treatment, the favorable prognosis rate was higher in the temperature treatment group than that in the conventional treatment group ( RR=1.41, 95% CI 1.32, 1.50, P<0.01), and mortality rate was lower than that in the conventional treatment group ( RR=0.64, 95% CI 0.55, 0.75, P<0.01). Compared with the conventional treatment group, the incidences of epilepsy and acute gastrointestinal dysfunction in the temperature treatment group were statistically reduced ( RR=0.33, 95% CI 0.13, 0.83, P<0.05; RR=0.43, 95% CI 0.25, 0.74, P<0.05). There were no statistically significant differences in the incidence of pulmonary infection ( RR=0.96, 95% CI 0.85, 1.08, P>0.05), intracranial infection ( RR=0.56, 95% CI 0.20, 1.56, P>0.05), deep vein thrombosis ( RR=0.93, 95% CI 0.69, 1.25, P>0.05), abnormal coagulation function ( RR=1.19, 95% CI 0.43, 3.31, P>0.05) or arrhythmia ( RR=0.51, 95% CI 0.23, 1.12, P>0.05) between the two groups. Egger′s test indicated the presence of publication bias and the results remained robust after trim and fill analysis. Conclusions:For patients with sTBI, temperature control therapy shows lowered intracranial pressure and mortality rate as well as improved favorable prognosis rate at 6 months posttreatment, and decreased incidence of epilepsy and acute gastrointestinal dysfunction during treatment, while reveals similar incidence of pulmonary infection, intracranial infection, deep vein thrombosis, abnormal coagulation function, and arrhythmia when compared with conventional treatment.

Chronic kidney disease(CKD)comprises a group of clinical syndromes affecting kidney structure and function,with various causes,high treatment costs,and a poor prognosis.Epigenetic modification of gene expression and cell function has been shown to play a key regulatory role in the occurrence and development of CKD.Homocysteine(Hey)is a common amino acid-containing thiol group in the body.Hyperhomocysteinemia(HHcy)is a damaging condition involving many organs,and is an independent predictor of end-stage renal disease morbidity and mortality.This review considers the relationship between HHcy and chronic renal injury,and examines research progress in the role of epigenetic modification in the mechanism of Hcy-mediated chronic renal injury,with the aim of furthering our understanding of the occurrence and development of CKD.This process and its mechanism provide new ideas and a theoretical basis for further research into CKD.

BACKGROUND:The"inflammatory storm"induced by microglia is an important pathological factor causing the death of neuronal cells after spinal cord injury,which is extremely unfavorable for the recovery after spinal cord injury.Dihydroquercetin belongs to the vitamin P group and has excellent biological activity.It has good anti-inflammatory,anti-lipid peroxidation and neuroprotective effects on spinal cord injury.The mechanism by which it promotes the repair of spinal cord injury needs to be further clarified.OBJECTIVE:To investigate whether dihydroquercetin can ameliorate the inflammatory state induced after spinal cord injury through its anti-inflammatory and antioxidant properties for the purpose of protection against spinal cord injury.METHODS:Forty-eight Sprague-Dawley rats were divided into sham operation group,spinal cord injury group,low-dose dihydroquercetin group,and high-dose dihydroquercetin group according to the random number table method.The sham operation group only underwent laminectomy and was given intraperitoneal injection of normal saline after the operation.Animal models of spinal cord injury were made in the latter three groups.After the operation,normal saline,30 mg/kg,and 50 mg/kg dihydroquercetin were given by intraperitoneal injection respectively,and samples were collected 4 weeks after the operation.The Basso-Beatte-Bresnahan(BBB)limb motor function score and mechanical paw withdrawal threshold were used to evaluate the limb motor function and pain recovery of rats.Hematoxylin-eosin staining was used to observe the pathological changes of spinal cord tissue;Nissl staining was used to observe the number of Nissl bodies and the morphology of neurons.The activity of superoxide dismutase in spinal cord tissue was detected.Immunofluorescence was used to detect the expression of reactive oxygen species and microglia Iba1.Western blot was used to detect the protein expression of Iba1 and interleukin-1β,interleukin-6,interleukin-10,tumor necrosis factor-α,and p38 mitogen-activated protein kinase in the spinal cord.RESULTS AND CONCLUSION:(1)In the behavioral test,the BBB limb motor function score showed that since 14 days after the operation,the BBB limb motor function score of the high-dose dihydroquercetin group was significantly better than that of the spinal cord injury group(P<0.01);the mechanical paw withdrawal threshold was significantly lower in the high-dose dihydroquercetin than the spinal cord injury group at 21 days after the operation(P<0.05),and the former group showed better motor function.(2)Hematoxylin-eosin staining and Nissl staining showed that compared with the spinal cord injury group,the high-dose dihydroquercetin group showed slightly swollen but structurally intact and clearer neuron morphology in the spinal cord tissue,and the number of Nissl bodies increased.(3)Superoxide dismutase detection:Compared with the spinal cord injury group,the activity of superoxide dismutase in the spinal cord tissue of the high-dose dihydroquercetin increased significantly(P<0.05).(4)Reactive oxygen species immunofluorescence detection:Compared with the spinal cord injury group,the high-dose dihydroquercetin could significantly reduce the accumulation of reactive oxygen species after spinal cord injury(P<0.05).(5)Detection of microglial marker Iba1:Compared with the spinal cord injury group,the high-dose dihydroquercetin could significantly reduce the expression of microglial marker Iba1 after spinal cord injury(P<0.01).(6)Western blot detection results showed that compared with the spinal cord injury group,the expressions of inflammatory factors(interleukin-1β,interleukin-6,and tumor necrosis factor-α)and phosphorylated p38 mitogen-activated protein kinase in the high-dose dihydroquercetin group decreased significantly(P<0.01),while the expression of anti-inflammatory factor interleukin-10 increased significantly(P<0.01).These findings indicate that dihydroquercetin can effectively reverse the expression changes of multiple inflammatory markers induced after spinal cord injury in rats,thereby exerting neuroprotective effects and improving motor function.

ObjectiveTo observe the clinical efficacy of modified Zuojinwan granules in treating reflux esophagitis （RE） and functional dyspepsia （FD） with the same syndrome with disharmony between liver and stomach）. MethodA randomized double-blind placebo-controlled clinical trial was conducted to enroll 144 patients with disharmony between liver and stomach， including 72 patients with RE and 72 patients with FD. These patients were then randomly divided into observation and control groups， with 36 patients in each group. The observation group was given modified Zuojinwan granules orally， and the control group was given placebo granules orally. They both were treated with two packs each time， twice a day， for four weeks. The traditional Chinese medicine （TCM） syndrome scores， cerebrointestinal peptides ［calcitonin gene-associated titanium （CGRP）， vasoactive intestinal peptide （VIP）， 5-hydroxytryptamine （5-HT）， and substance P （SP）］， inflammatory factors ［tumor necrosis factor-α （TNF-α） and interleukin-6 （IL-6）］， common gastrointestinal related hormones ［gastrin （GAS） and motilin （MTL）］， and other indicators in the two groups were compared before and after treatment， and the curative effect of TCM syndromes and the occurrence of adverse reactions were determined. At the same time， the changes in the above indicators and the curative effect of TCM syndromes in the two groups of patients with the same disease were analyzed. ResultAfter treatment， CGRP， VIP， 5-HT， SP， TNF-α， IL-6， GAS， MTL， and TCM syndrome scores in the observation group and control group were significantly improved （P<0.05）. After treatment， the improvement of CGRP， VIP， 5-HT， SP， TNF-α， IL-6， GAS， MTL， and TCM syndrome scores in the observation group was better than that in the control group （P<0.05）. After treatment， CGRP， VIP， 5-HT， SP， TNF-α， IL-6， GAS， MTL， and TCM syndrome scores in both groups of RE patients and FD patients were significantly improved （P<0.05）. After treatment， the improvement of CGRP， VIP， 5-HT， SP， TNF-α， IL-6， GAS， MTL， and TCM syndrome scores in RE patients and FD patients in the observation group were better than that in the control group （P<0.05）. In the observation group and the control group， the incidence of nausea， vomiting， fatigue， dry mouth， and other adverse reactions was lower， and there was no statistical significance. ConclusionModified Zuojinwan granules can effectively improve the TCM syndromes of disharmony between liver and stomach of RE and FD， brain and intestinal peptide， gastrointestinal hormone， and inflammatory factors and provide evidence for the clinical application of TCM theory of "treating different diseases with the same method".